ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Identification of Cell Types That Harbor Cytomegalovirus DNA in Acutely and Latently Infected Mice Spleen

    A. S. Maganti1, X. Liu2, M. Abecassis2

  • Identification of Eplet Mismatches Associated with De Novo Donor Specific HLA Antibody in a Pediatric Kidney Transplant Cohort

    O. Charnaya, J. Jones, P. Chiang, M. C. Philogene, J. Garonzik-Wang

  • Identification of Molecular Markers for Liver Cirrhosis (NASH) by Single-Nucleus RNA Sequencing

    C. Kuscu1, A. Mouhammed2, C. Kuscu3, A. R. Wolen3, J. D. Eason3, D. Maluf3, V. Mas3

  • Identification of Novel Gene Targets Inducing Resistance in Liver Ischemia Reperfusion Injury by CRISPR Screening

    C. Kuscu, A. R. Wolen, C. Kuscu, C. Watkins, A. Bajwa, J. D. Eason, D. Maluf, V. Mas

  • Identification of the dnDSA Inducing HLA Mismatches Across Multiple Renal Transplant Centers: A 3-Year Longitudinal Analysis of >11,000 HLA Mismatches in 2271 Patients

    J. M. Brennan1, M. D. Stegall2, C. A. Schinstock2, R. L. Heilman3, L. M. Rebellato4, M. D. Samaniego-Picota5, D. Lesser4, M. J. Ghandi2, J. L. Beaumont1, M. J. Everly1

  • Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates

    A. Kardashian1, J. Ge1, C. McCulloch1, M. R. Kappus2, M. A. Dunn3, A. Duarte-Rojo3, M. L. Volk4, R. S. Rahimi5, E. C. Verna6, D. R. Ganger7, D. Ladner7, J. L. Dodge1, B. Boyarsky8, M. McAdams-DeMarco8, D. L. Segev8, J. C. Lai1

  • Identifying Factors Associated with Delayed Graft Function Severity Using the OPTN Database

    K. Checchi1, D. Stewart2, A. Toll2, J. Case1, S. Kurian1, C. Marsh1

  • Identifying Optimal Recipients for DCD Livers: Minimizing Risks of Liver Transplantation with DCD Livers by Matching to Preferred Recipients

    K. R. Jackson, J. Motter, A. Massie, J. Garonzik-Wang, D. Segev

  • Ifnar Signaling on Myeloid Cells Does Not Contribute to Costimulation Independent Transplant Rejection

    J. Habib, D. Mathews, Y. Dong, A. Stephenson, A. Adams

  • IgA Nephropathy Outcomes after Kidney Transplantation in an Early Corticosteroid Withdrawal Center

    S. Kurian1, S. Spierling2, B. Barrick1, J. Rice1, J. Case1, C. Marsh1

  • Ikaros Regulates Macrophage Inflammation in Liver Ischemia-Reperfusion Injury: From Mouse-to-Human

    K. Kadono1, S. Kageyama1, K. Nakamura1, H. Hirao1, H. Kojima1, T. Ito1, K. J. Dery1, X. Li2, R. W. Busuttil1, F. Kaldas1, J. W. Kupiec-Weglinski1

  • IL-10 Exposure Enhances IRAK-M Expression to Promote Endotoxin Tolerance and the T Cell Tolerogenic Potential of Liver Conventional DCs

    Y. Zheng, R. Nakano, A. Thomson

  • IL-10 Signaling in T Cells is Essential for Induction of Transplant Tolerance

    M. Iglesias Lozano, D. Bibicheff, M. Chicco, G. Brandacher, G. Raimondi

  • IL-21, a Potential Target of Active Rejection in Renal Transplantation

    J. Shen, R. Wang, L. Guo, J. Lv, J. Wu, J. Chen

  • IL-33 is a Potent Injury Signal That Programs Graft Macrophage Metabolism Toward That Required for Reparative and Regulatory Functions

    T. Li1, Z. Zhang1, Q. Liu1, J. Bartolacci2, M. Velayutham1, G. Hussey2, J. Dziki2, L. Mathews1, Y. Lee3, G. Dwyer1, H. Dai1, A. Roessing1, S. Shiva4, M. Oberbarnscheidt1, S. Badylak2, H. Turnquist1

  • IL-6 Receptor Blockade But Not IL-2 Treatment Contributes to Long-Term NHP Cardiac Allograft Survival in Transient Mixed Chimeras

    K. Ahrens1, J. M. O1, W. Sommer2, J. Morrissette1, D. Becerra1, P. M. Patel1, T. Costa1, A. Dehnadi1, I. M. Hanekamp1, J. S. Allan3, G. Benichou1, J. C. Madsen4

  • IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse

    A. Flecha

  • Imaging Features and Diagnostic Accuracy of MRI in Combined Hepatocholangiocarcinoma

    M. Najjar1, J. Makkar1, S. Sun1, J. Zou1, O. Perez1, P. Jiang1, Y. Saenger1, E. Zheng1, E. Verna1, A. Mathur1, A. Griesemer1, K. Halazun2, B. Samstein2, T. Kato1, J. Emond1

  • Imaging OX40+Alloreactive T Cells Provides Early Warning of Organ Transplant Rejection

    T. Hirai1, A. Mayer2, T. W. Nobashi2, Z. Xiao2, T. Udagawa3, K. Seo4, F. Simonetta5, J. Baker5, A. Cheng3, S. S. Gambhir2, R. S. Negrin5

  • Immune Cell Subset Profiles in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts) Desensitized with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Followed by Transplantation (Tx)

    S. Ge1, M. Chu1, A. D. Guzman1, E. D. Ortiz1, A. Vo2, N. Ammerman2, S. C. Jordan2, M. Toyoda1

  • Immune Checkpoint Inhibitor Use in Kidney Transplant Recipients: Rejection Risk, Prevention and Transcriptional Signature in Allograft

    N. Murakami1, G. Reid2, A. Weins1, B. Adam2, M. Mengel2, L. Riella1

  • Immune Checkpoint PD-L1 Pathway as an Effective Platform for Localized Immunomodulation to Attain Indefinite Allogeneic Islet Graft Survival

    L. Batra1, P. Shrestha1, H. Zhao1, K. B. Woodward1, M. Tan1, O. G. Nuno1, A. Togay1, M. M. Coronel2, A. J. Garcia2, H. Shirwan1, E. S. Yolcu1

  • Immune Response Following Cardiac Progenitor Cells Transplantation in Rat Myocardial Infarction Model

    M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, L. Wang, M. Yasir Arfat, X. Fu, S. Kaushal

  • Immune-Mediated Injury and Eplet Mismatches – Profiling Population-Level Interactions

    H. Mohammadhassanzadeh1, W. Zhang2, W. Klement3, H. Gebel4, P. Keown5, K. Oualkacha6, R. Sapir-Pichhadze1

  • Immuno-Modulation of Primed Xenogeneic T Cell Response by mTOR Blockade of T Cells and Porcine Endothelial Cells

    S. Li, A. Kirk, H. Xu

  • Immunohistochemical and Molecular Detection of NK Cells in Kidney Allografts with Antibody Mediated Rejection

    E. Farkash, J. Barnes, S. Anand

  • Immunomodulation During Normothermic Ex Vivo Machine Perfusion of the Rat Liver

    K. Carlson1, F. Najmabadi1, J. Pavan-Guimaraes1, W. J. Burlingham1, C. M. Capitini2, D. P. Al-Adra1

  • Immunomodulation with FasL Presenting Biomaterials Achieves Long-Term Survival of Allogeneic Islets in the Absence of Chronic Immunosuppression in a Non-Human Primate Model

    J. Lei1, H. Deng1, T. Chen1, K. Lee1, C. Peters1, Z. Yang1, K. Deng1, G. Rickert1, I. Rosales1, N. Serifis1, M. Coronel2, M. Hunckler2, E. Yolcu3, H. Shirwan3, A. García2, J. Markmann1

  • Immunosurveillance with Donor Derived Cellular Free DNA Assay Plus Donor Specific Antibody, an Alternative to Renal Allograft Biopsy

    S. Machado, G. Agarwal, F. Ahmed, B. Julian, R. Mannon, S. Mehta, V. Kumar, S. Ong, S. Thaduri, G. Towns, C. Kew

  • Impact and Outcomes of Primary Cytomegalovirus Infection in Seronegative Abdominal Solid Organ Transplant Recipients of Cytomegalovirus Unexposed Donors (D-/R-)

    M. Jorgenson1, M. Hillis1, N. Friedlander1, A. Gracon2, D. Yang2, G. Leverson2, J. Smith2, R. Redfield2

  • Impact of a De Novo Belatacept Based Immunosuppressive Regimen on Kidney Transplant Outcomes

    K. Joyal, T. Vanhove, B. Schreiber, M. Cote, S. Shao, N. Elias, H. Gilligan, K. Safa, E. Heher, W. Williams, C. Rogers

  • Impact of a Pharmacist Led Outpatient Tacrolimus Monitoring Protocol in Renal Transplant Recipients

    K. L. Owen, M. Palettas, H. Winters, T. E. Pesavento, A. Rajab, O. Witkowsky

  • Impact of Alemtuzumab Induction on Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Recipients

    M. Plazak1, X. Gao2, S. Gale2, B. Reed2, R. Madathil1, S. Hammad1, B. Ravichandran1

  • Impact of Allograft Nephrectomy on Outcomes in Second Kidney Transplantation

    N. Sato, Y. Kakuta, T. Kanzawa, K. Unagami, M. Okumi, H. Ishida, K. Tanabe

  • Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection

    D. Kumar1, I. Yakubu1, S. Paluri1, A. Chachar1, J. Chang2, I. Moinuddin1, L. Kamal1, M. Levy1, C. Bhati1, A. King1, P. Kimball1, P. Halloran2, G. Gupta1

  • Impact of Body Mass Index on Methodsof Assessing Glomerular Filtration Rate in Living Kidney Donors

    Y. Lu1, A. Naik1, R. Doshi2, K. Woodside3, M. Doshi1

  • Impact of Catch-Up Vaccinations on Anti-HLA Antibody Responses in Pediatric Kidney Transplant Candidates

    H. Sweiss1, J. Lyons2, R. Hall1, K. Hitchman3, D. Ranch4, E. Kincaide1, B. Crowther5

  • Impact of Center Volume and MELD on Textbook Outcome Rates in Liver Transplantation

    A. D. Schenk, J. L. Han, A. J. Logan, J. M. Sneddon, G. L. Brock, W. K. Washburn

  • Impact of Chronic Changes on Preimplantation Biopsy (PBx) on Outcomes after Deceased Donor Kidney Transplantation (DDKTx)

    J. Ninan, R. Heilman, M. Smith, J. Harbell, S. S. Nair, C. Jadloweic, H. Khamash, A. Moss, K. S. Reddy

  • Impact of Concentrations on Conversion from Twice‑Daily to Once‑Daily Tacrolimus in Stable Kidney Graft Recipients: A Single-Center Retrospective Study

    Z. Wang, Y. Cao, Y. Fu

  • Impact of County Health Rankings on Nationwide Liver Transplant Outcomes

    S. K. Niazi1, E. Vargas2, A. Spaulding3, J. Crook4, A. P. Keaveny5, T. Schneekloth6, T. Rummans7, C. Taner5

  • Impact of CYP3A5 Phenotype on Early Time in Therapeutic Range among Pediatric Renal and Heart Transplant Recipients

    A. Leino, A. Pasternak

  • Impact of Delayed Kidney Graft Function (DGF) after Simultaneous Liver and Kidney Transplantation (SLKT) on Patient Outcomes: Results from the US Multicenter SLKT Consortium

    P. Sharma1, Z. Sui1, M. Zhang1, J. Magee1, P. Barman2, K. Walters3, A. Schluger4, R. Wong5, G. Cullaro6, J. Sinha7, J. Jo7, Y. Patel8, S. Biggins9, J. Lai5, L. VanWangner7, E. Verna6

  • Impact of Depleting Induction Agents on BK Virus and Polyomavirus Associated Nephropathy

    J. Clark1, A. Barlow1, A. Haririan2

  • Impact of Desensitization Strategies with Proteosome Inhibition and Costimulation Blockade on Xenoreactive Humoral Responses

    B. P. Lovasik1, A. J. Matar1, D. A. Faber1, D. V. Mathews1, C. P. Breeden1, S. C. Kim1, A. J. Tector2, A. B. Adams1

  • Impact of Dialysis and Diabetes on Survival in Recipients of Combined Heart-Kidney Transplant

    J. Parekh1, H. Chau2, G. Schnickel2, J. Berumen2, K. Mekeel2

  • Impact of Donation after Circulatory Death Allografts on Outcomes Following Liver Re-Transplantation in the United States

    S. Kumar1, S. Lin2, J. D. Schold2

  • Impact of Donor Lung Pathogenic Bacteria Detected by Next-Generation Sequencing on Early Post-Transplant Outcomes in Lung Transplant Recipients

    D. Liu, J. Zhang, J. Chen

  • Impact of Donor Multidrug-Resistant Organisms on Risk of Recipient Infection

    J. A. Anesi1, E. A. Blumberg1, J. H. Han2, D. H. Lee3, H. Clauss4, R. Hasz5, E. Molnar4, D. Alimenti1, A. R. Motzer4, S. West5, W. B. Bilker1, P. Tolomeo1, E. Lautenbach1, T. Prevention Epicenters Program6

  • Impact of Donor Noninvasive Liver Fibrotic Score on Graft Injury in Liver Transplantation

    S. M. Younan, T. Ito, H. Hirao, A. Aziz, A. E. Murray, J. DiNorcia III, V. G. Agopian, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Impact of Donor Race on Tacrolimus Dose Requirement for Liver Transplant Recipients

    N. Nesselhauf1, S. January1, J. Hagopian1, K. Progar1, A. Khan2

  • Impact of Enhanced Recovery after Surgery Protocols on Robotic Living Kidney Donor Outcomes: A Single Center Experience

    B. Ruch, A. Sharma, J. Amery, C. Bhati, A. Khan, A. Cotterell, M. Scott, M. Levy

  • Impact of Eplet Mismatches on the Risk of Graft Loss: Not All Eplets are Created Equal

    H. Mohammadhassanzadeh1, W. Klement2, H. Gebel3, B. Foster4, P. Keown5, K. Oualkacha6, R. Sapir-Pichhadze1

  • Impact of Extended- versus Immediate-Release Tacrolimus on One-Year Development of De Novo DSA and Chronic Immune Activation in Kidney Transplantation (ASTOUND Study)

    A. Wiseman1, D. Kaufman2, A. Patel3, D. Wojciechowski4, A. Tambur5, J. Kim6, J. Schwartz6

  • Impact of Extracorporeal Photopheresis in a Full-Mismatch Kidney Transplant Rat Model

    J. Rovira1, G. J. Piñeiro2, M. Lazo-Rodriguez3, M. J. Ramirez-Bajo1, E. Banon-Maneus3, N. Hierro-Garcia3, P. Ventura-Aguiar2, J. Cid4, M. Lozano4, F. Diekmann2

  • Impact of Focal Cortical Necrosis (CN) in Preimplantation Biopsy (PBx) on Outcomes after Deceased Donor Kidney Transplantation

    S. S. Nair, J. Ninan, R. Heilman, K. Reddy, M. Smith

  • Impact of Frailty on Early and Late Hospital Readmission after Kidney Transplantation

    H. Hendra1, B. Sandhu2, E. Frackiewicz2, G. Jones2, P. Masson2, R. Motallebzadeh3

  • Impact of Functional Status on Outcomes of Simultaneous Pancreas-Kidney Transplantation: Risks and Opportunities for Patient Benefit

    K. Lentine1, T. Alhamad2, M. Cooper3, Z. Zhang4, K. Woodside5, D. Dadhania6, S. Chang2, D. Axelrod7, M. Schnitzler4, R. Ouseph1, J. Snyder8, B. Kasiske8, R. Parsons9

  • Impact of Immunogenicity on Kidney Allograft Survival in Patients Treated with Induction Therapy

    R. Michael, B. Mierzejewska, D. Bekbolsynov, J. Ortiz, O. Ekwenna, S. Stepkowski

  • Impact of Immunosuppression on Quality of Life among HLA-Identical Living Kidney Recipients at UCLA – A Qualitative Study

    E. L. Wood1, S. George2, N. Kogut1, E. Lum, MD3, J. L. Veale1

  • Impact of Immunosuppression Protocol on the Incidence of EBV Viremia and PTLD in Pediatric Kidney Transplant Recipients: A Single Center Experience

    K. Bowers1, V. M. Panzarino1, A. Campos1, J. Buggs2, V. D. Bowers2

  • Impact of Infectious Disease Intervention on Vaccine Compliance in Pediatric Heart Transplant Patients

    S. R. Lauhon1, G. Stendahl2, P. Simpson3, S. J. Kindel2, A. R. Punnoose2, A. R. Huppler2

  • Impact of Kidney Allocation System on Waiting List Outcomes for Candidates Listed in Veterans Affairs Programs

    J. Walker1, B. Concepion2, K. Birdwell2, I. Feurer3, S. Rega4, D. Shaffer5, R. Forbes5

  • Impact of Kidney Donor Profile Index (KDPI) on Long-Term Outcomes in Deceased Donor Renal Transplant Recipients with Donor Acute Kidney Injury

    A. Brar1, M. Salifu2, D. Adey1, A. Gruessner2

  • Impact of Kidney Transplant Type and Previous Transplant on Baseline Donor-Derived Cell Free DNA

    K. K. Sureshkumar, B. Chopra

  • Impact of Liver Graft Preservation Methods on the Gut Microbiome and Metabolome

    G. A. Cresci1, N. Sangwan2, A. Simioni3, Q. Liu3, C. Quintini3

  • Impact of Low Dose Donor Specific Anti-HLA Antibodies between Living Donor versus Deceased Donor Kidney Transplantation

    S. Kim1, S. Lee1, E. Ko1, T. Ban2, J. Min3, H. Yoon4, C. Yang1, B. Chung1

  • Impact of New Onset Atrial Fibrillation on Clinical Outcomes in Liver Transplant Recipients

    C. M. Anugwom1, S. Jackson2, T. Pruett3, N. Lim1

  • Impact of Non-Active Hepatitis B after Renal Transplantation

    M. G. Naik, W. Duettmann, M. Mayrdorfer, F. Halleck, K. Budde, M. Duerr

  • Impact of Nursing Education on Organ Donation

    J. Yeh1, M. Corcoran2, M. Jarrett2, V. Nair1, L. Teperman1

  • Impact of Organ Donor Infections on Kidney Transplant Recipient Outcomes

    M. Santarossa1, C. Muran2, S. Sanchez2, L. Heinrich2, J. Yoo3, F. Albarillo1, S. Akkina3, N. Clark1, G. Reid1

  • Impact of Ozone Exposure of Lung Donors and Recipients on All-Cause Mortality after Lung Transplant

    T. Egan1, S. Arunachalam2, C. Chang2, P. Strassle1

  • Impact of Patent Foramen Ovale on Post Liver Transplant Neurological Outcomes

    S. Naffouj, F. Nimri, M. Mohammed, E. Abu-Asala, L. Al-khatib, M. Abu-Ghanimeh, D. Venkat

  • Impact of Patients’ Perception of Hospital Experience on Organ Donation Rates

    A. Azim1, A. Friedman2, S. Nishida1, K. Okumura1, G. Veillette1, T. Diflo1, R. Latifi1, H. Sogawa1

  • Impact of PD1, PDL1 Gene Polymorphisms on Allo-Immune Responses after Kidney Transplantation

    H. Yamane, Y. Tanaka, M. Ohira, H. Tahara, K. Ide, H. Ohdan

  • Impact of Pre-Liver Transplant Cardiovascular Disease Risk Assessment Standardization on Resource Utilization and Recipient Selection

    J. Rice1, D. Hughes1, J. R. Burton1, E. D. Pomfret2, J. J. Pomposelli2, A. V. Ambardekar3, M. Kriss1

  • Impact of Pregnancy on Kidney Transplant Recipients: A Propensity Score-Matched Study

    T. Abe, A. Taniguchi, M. Kawamura, S. Nakazawa, T. Kato, R. Imamura, N. Nonomura

  • Impact of Pretransplant Malignancy on Heart and Lung Transplant Recipients

    W. Kang1, C. T. Sparrow2, M. Kim1, M. Rachid3, S. M. Soriano3

  • Impact of Recipient Obesity on Kidney Transplantation Outcome: A Retrospective Cohort Study with a Matched Comparison

    A. Buemi1, L. Romero1, F. Zech2, T. Darius1, M. De Meyer1, A. Devresse3, N. Kanaan3, E. Goffin3, M. Mourad1

  • Impact of Renal Transplant on the Outcomes of Breast Cancer Surgery

    A. Choubey1, A. Parsikia2, D. Samson2, M. Castaldi2, R. Latifi2, J. Ortiz1

  • Impact of Rituximab and Apheresis Techniques in Acute Rejection Rates in ABO Incompatible Living Donor Kidney Transplant

    I. Revuelta1, E. De Sousa-Amorim1, M. Lozano2, D. Cucchiari1, J. Cid2, L. Peri3, E. Palou4, M. Musquera3, J. Martorell5, J. M. Campistol1, F. Oppenheimer1, F. Diekmann1

  • Impact of Sarcopenia on Simultaneous Pancreas and Kidney Transplantation Outcomes: A Retrospective Observational Cohort Study

    R. P. Meier, H. Noguchi, Y. Kelly, M. Sarwal, G. Conti, R. Halleluyan, M. Tavakol, P. Stock, C. Freise

  • Impact of Severity of Glomerulosclerosis on Long-Term Outcomes in Deceased Donor Renal Transplant Recipients with Donor Acute Kidney Injury

    A. Brar1, A. Gruessner2, D. Adey1, M. Salifu2

  • Impact of Statin Intensity on the Development of Cardiac Allograft Vasculopathy

    K. Goehring1, W. Kuan1, A. Sieg1, K. L. Dawson1, A. R. Kolodziej2

  • Impact of the 2015 LAS Revisions on Lung Candidates with Pulmonary Vascular Disease

    K. Lindblad1, R. Goff1, K. Chan2

  • Impact of the Baseline Anti-A/B IgG Titer on the Clinical Outcome in ABO-Incompatible Liver Transplantation

    J. Lee1, E. Kim1, S. Yang1, D. Kim2, M. Ju3, J. Lee1, M. Kim1, S. Kim1, D. Joo1

  • Impact of Timing of T Cell Mediated Rejection in the First Year after Kidney Transplantation

    R. Mehta, D. Jorgensen, C. Puttarajappa, S. Hariharan, R. Mehta, P. Sood

  • Impact of UNOS Acceptance Sequence Number on Liver Graft Survival

    C. Thornley, O. Kezirian, S. Mehta, J. Cashman, J. Brink, T. Chaly Jr, W. Van der Werf

  • Impact of Variation in Histological Assessments and Their Impact on Clinical Trial Enrollment and Endpoints – Preliminary Report of The Gen04 Study

    W. Park1, M. Ryan2, L. Herrera Hernandez3, M. Smith2, X. Geiger4, T. Sandor5, L. Cornell3, M. Stegall1

  • Impact of Worsening Renal Function While Waiting for Heart Transplantation

    A. Kumar1, C. P. Thomas2

  • Impact on Graft Histology of Steroid Withdrawal versus Standard Immunosuppression: Randomized, Parallel Group, Controlled Clinical Trial in Low Immunological Risk Kidney Transplant Patients

    E. Gutiérrez Vílchez1, T. Vázquez1, V. López1, M. León2, E. Sola1, J. Sellares3, M. Cobo4, J. Cruzado5, A. Torío6, J. Kanter7, P. Ruiz-Esteban1, D. Hernández1

  • Implementation of a Pharmacist in an Adult Transplant Outpatient Clinic (Kidney, Liver, Pancreas): A Pilot Study – Implant

    P. Leveille-Dugas1, C. Bernard1, L. Loiselle1, Y. Zhang1, C. Coursol1, K. Mousseau1, N. Sheehan1, M. Cantarovich2

  • Implementing a Height Based Rule for Allocation of Pediatric Donor Livers to Adults – A Liver Simulated Allocation Model (LSAM) Study

    J. Ge1, W. L. Nicholas2, S. Gentry2, J. C. Lai1

  • Implications for Facilitated Pancreas Transplant Allocation with the Removal of Donor Service Area

    R. Forbes1, R. Urban2, A. Fox2, J. Odorico3, S. Niederhaus4

  • Implicit Bias in Recipient Selection

    Y. Sweidan1, C. Mayuga1, B. Daly1, K. Chavin2, T. Srinivas1, A. Padiyar1

  • Improved Kidney Function Post Lung Transplant with Intravenous Tacrolimus Avoidance

    C. Burt1, A. Feist1, K. Afshar2, L. Awdishu1, M. Mariski1, J. Kozuch1, G. Yung2, E. Golts3

  • Improved Medication Safety Outcomes with a Mobile Health, Pharmacist-Led Intervention: Results of the TRANSAFE Rx Randomized Controlled Trial

    H. Gonzales, J. Fleming, M. Gebregziabher, J. McGillicuddy, D. Taber

  • Improved Outcomes Over the Past 13 Years in HIV Positive Kidney Transplant Recipients-A Single Center Experience

    A. Mattiazzi1, J. F. Camargo2, S. Anjan2, M. I. Morris2, L. Abbo2, J. Simkins2, Y. Natori2, K. Aoke3, A. Zilli3, R. Thurston3, M. Muldoon3, L. Preczewski3, L. J. Chen4, G. W. Burke4, G. Ciancio4, G. Guerra1

  • Improved Platelet Sequestration with Humanization of Von Willebrand Factor in Pig Xenogeneic Lung Perfusion Model

    M. R. Connolly1, L. Burdorf1, Z. Abady1, S. Sendil2, E. Redding2, B. Cerel1, S. Pratts1, C. Phelps3, W. Eyestone3, D. Ayares3, A. Azimzadeh1, R. N. Pierson III1

  • Improved Serum Vitamin D Level and Better Cardiovascular Disease Outcomes after Kidney Transplantation

    J. Ryu1, T. Koo2, H. Jeon3, C. Ahn4, J. Yang5

  • Improved Survival of Acute Liver Failure by “Off-the-Shelf” Bioartificial Liver Support System Using Immobilized Cryopreserved Hepatocyte Spheroids in Porcine Model

    S. Lee1, J. Lee2, H. Park2, Y. Kim2, J. Noh3, J. Jung3, S. Lee3, H. Shin3, H. Yoon4, D. Lee3, S. Lee1

  • Improvement in Long Term Kidney Transplant Survival Most Dramatic among Minorities, Diabetics and Older Patients

    E. D. Poggio1, S. Arrigain2, A. Wee3, D. C. Brennan4, J. D. Schold2

  • Improvement of Renal Function Prior to Liver Transplantation is Not Associated with Better Long-Term Renal Outcome or Mortality

    M. Sterneck1, T. Horvatits2, M. Touma2, U. Herden3, A. Lohse2, L. Fischer3

  • Improvements in Organ Donation: Riding the Coattails of a National Tragedy

    D. Goldberg1, R. Lynch2

  • Improving Access to Transplantation and Outcomes for African American Patients

    D. Bekbolsynov, O. Ekwenna, B. Mierzejewska, J. Borucka, S. A. Khuder, M. Rees, R. Green, S. Stepkowski

  • Improving Consent Rate for High Kidney Donor Profile Index Kidneys

    L. Malinzak, A. Patel, A. Malilay, K. Dandron, A. Landrum, S. Gray, L. Lewis, K. Lord, R. Stampley, D. Kim

  • Improving DRG Based Reimbursement to Reflect Complexity of Kidney Transplant

    I. R. Schwantes1, M. Schnitzler2, K. Lentine2, A. Reed1, D. A. Axelrod3

  • Improving Eligibility of Renal Transplants in the Elderly

    L. B. Moraitis1, J. Rogers2, A. Farney1, A. Reeves-Daniel1, G. Orlando1, W. Doares1, S. Kaczmorski1, A. Mena-Gutierrez1, C. Jay1, R. Stratta1

  • Improving Evaluation and Follow-Up of Living Kidney Donors: Role of Radioisotopic Glomerular Filtration Rate and Renal Functional Reserve

    V. Cantaluppi1, G. Guglielmetti1, U. M. Morosini1, A. Nappo1, G. Merlotti1, A. Airoldi1, M. Quaglia1, C. Ronco2

  • Improving Liver Transplant (LT) Waitlist Attrition

    W. Concepcion1, A. Ahmed1, Z. Tulu2, L. Hogan2, A. Bonham1, A. Gallo1, M. Melcher1, P. Kwo1, C. Esquivel1

  • Improving Vaccination Rates for Influenza and Pneumococcal Disease in Pediatric Kidney Transplant Recipients

    A. M. McGrath1, J. Baquir1, L. Maestretti1, G. James1, K. DiNello1, M. Patton1, A. Fong1, A. Gallo2, V. Sigurjonsdottir2, P. Grimm2, A. Chaudhuri2

  • Improving Value Delivery in Living Donor Kidney Transplant Through Process Improvement

    S. Anand, J. Browning, W. Stapley, M. Egbert, J. Krong, J. Zobell, A. Herbert, S. Dow, L. Dong, D. Morris, T. Srinivas

  • In a Murine Model of Acetaminophen-Mediated Liver Injury, Tubastatin-a, An Hdac6-Specific Inhibitor, Improves Survival and Decreases Hepatocellular Injury

    C. S. OBrien1, P. T. Hernandez1, S. J. Concors1, L. N. Krumeich1, Z. Wang1, G. Ge1, T. Bhatti2, A. Kozikowski3, W. Hancock2, M. H. Levine1

  • In Silico Deconvolution of Whole Blood RNA-Seq Data from Iscalimab Phase IIa Study in Renal Transplant Reveals Insights Into Mechanism of Action and Superiority of Iscalimab Compared to Tacrolimus

    J. S. Rush

  • In Vivo Phosphorylation of C-MET by ANG-3777, A Hepatocyte Growth Factor Mimetic

    L. Paka, I. D. Goldberg

  • In-Depth Assessment of Ischemia/Reperfusion Injury in a Murine Model of Hindlimb Transplantation

    F. Messner1, K. Kadono2, Y. Guo1, B. Oh1, J. Kupiec-Weglinski2, G. Brandacher1

  • In-Vivo Application of Ides (Imlifidase) in Nonhuman Primates Results in Xenoreactive Desensitization: A Novel Anti-Humoral Therapy

    B. P. Lovasik1, A. J. Matar1, D. A. Faber1, D. V. Mathews1, C. Breeden1, S. C. Kim1, A. J. Tector2, A. Robertson3, C. Kjellman3, A. B. Adams1

  • Inactive Status Change is an Independent Predictor of Waitlist Mortality and Disproportionately Impacts Patients in Donor Service Areas with a Higher Median MELD at Transplant

    R. Batra1, S. Noreen2, D. Stewart3, D. Haakinson1, G. Gan3, Y. Deng3, S. Kulkarni1

  • Inactive Status Changes Disproportionately Impacts the Probability of Obtaining a Deceased Donor Liver Transplant in Donation Service Areas with Higher MMaT

    D. Haakinson1, S. Noreen2, D. Stewart2, R. Batra1, G. Gan1, Y. Deng1, S. Kulkarni1

  • Incidence and Effects of Posttransplant Herpes Zoster in Adult Solid Organ Transplant Recipients : A Meta-Analysis

    S. H. Han, D. Kwon

  • Incidence and Influencing Factors of Venous Thromboembolism after Lung Transplantation

    L. Fan1, J. Chen2, B. Wu1, Z. Zhai3

  • Incidence and Outcomes of Secondary Cutaneous Malignancies among Renal Transplant Recipients

    T. Maw1, P. Vaidya1, J. Samaan2, S. Ghanshani1, G. In1

  • Incidence and Risk Factors of Post-Transplant Erythrocytosis in Deceased Donor Kidney Transplantation

    S. Alasfar, Y. Jia, I. E. Hall, H. Thiessen Philbrook, S. G. Mansour, M. D. Doshi, S. Mohan, J. S. Bromberg, P. P. Reese, C. Parikh

  • Incidence and Risks Factors of Kidney Allograft Loss Due to BK Virus in Pediatric Population: UNOS Data Set

    H. Patel1, K. Agrawal1, A. Pawar1, N. Rodig2, N. Agrawal1, F. Cardarelli1

  • Incidence and Risks Factors of Kidney Allograft Loss Due to BK Virus: UNOS Data Set

    H. Patel1, K. Agrawal1, A. Pawar1, N. Leeaphorn2, F. Cardarelli1, N. Agrawal1

  • Incidence of Antibody Mediated Rejection in Living Kidney Transplant Recipients with Sensitizing History

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • Incidence of Chronic Kidney Disease after Liver Transplantation Using Measured GFR

    N. R. Mazumder1, J. Levitsky1, G. Saracino2, G. Klintmalm3, J. Trotter2, S. Asrani2

  • Incidence of Cytomegalovirus and Role of Reduced Dose Valganciclovir in Kidney Transplant Recipients

    A. Szczepanik1, E. Metzker1, C. Burrelli1, K. Chavin2

  • Incidence of Cytomegalovirus Infection in Deceased Donor Kidney Transplantation from Hepatitis-C Antibody Positive Donors to Hepatitis-C Antibody Negative Recipients: A National Registry Analysis

    M. Yazawa1, T. Fülöp2, O. Cseprekal3, M. Talwar1, V. Balaraman1, A. Bhalla1, A. Azhar1, C. P. Kovesdy4, J. D. Eason1, M. Z. Molnar1

  • Incidence of Fragility Fractures and Changes in Bone Mineral Density in Type 1 Diabetes Recipients of Pancreas Transplant Alone

    Y. C. Kudva, S. Batthula, R. Kaur, B. H. Smith, S. R. Rizvi, P. G. Dean, W. K. Kremers, M. D. Stegall, R. A. Wermers

  • Incidence of Non-Tuberculous Mycobacteria in the Transplant Population at a University Transplant Center in Northern Florida

    D. Schain, Z. Breslow, G. El Helou, A. Cannella

  • Incidence of Oropharyngeal and Esophageal Candidiasis in Adult Kidney Transplant Recipients Receiving Nystatin versus No Prophylaxis

    L. Moreno1, K. Klein1, C. Long2, R. Hall1, J. Nelson1

  • Incidence of Rejection One Year after Liver Transplantation Associated with Early versus Late Steroid Withdrawal

    S. Yun, L. Miko, J. Ahmad

  • Incidence of Skin Cancer – A Long Term Outcome of Immunosuppression in Renal Transplant Recipients Associated with the Usage of Azathioprine

    H. Bheemreddy1, S. Yusuf1, N. Krishnan2, A. Imtiaz3

  • Incidence of Urinary Tract Infections in Kidney Transplant Recipients Receiving Alternate Antimicrobial Prophylaxis Regimens

    D. Quan1, J. Phillips1, E. Chiang1, V. Kuo2

  • Incidence, Clinical Correlates and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims

    K. Lentine1, S. Costa2, Y. Caliskan3, D. Levine4, J. Runo5, H. Te6, J. Rangaswami7, D. Dadhania8, D. Axelrod9, M. Schnitzler3, H. Xiao1, B. Kasiske10, J. Snyder10, T. Villines11

  • Incidence, Risk Factors, and Kidney Transplant Outcomes Associated with Post-Transplant Diabetes Mellitus

    R. F. Malik1, Y. Jia1, S. G. Mansour2, I. E. Hall2, M. D. Doshi2, P. P. Reese2, P. Singh2, M. N. Harhay2, F. L. Weng2, H. Thiessen Philbrook1, B. Schröppel2, T. Muthukumar2, J. S. Bromberg2, E. Akalin2, S. Mohan2, C. R. Parikh1

  • Incident Influenza Cases and Missed Opportunities for Vaccination among Solid Organ Transplant Recipients

    D. Abraham, H. J. Neumann, S. A. Mehta

  • Incident Malignancies among Post Kidney-Transplant Patients by Type of Induction Immunosuppression and by Age

    L. Wang, J. Motter, S. Bae, D. Segev, M. McAdams DeMarco

  • Increased Graft Survival Following Implementation of the Kidney Allocation Score

    M. L. Samoylova1, B. I. Shaw1, W. Irish2, S. J. Kesseli1, A. Connor1, A. S. Barbas1, L. McElroy1, K. V. Ravindra1

  • Increased Intra-Abdominal Pressure is Associated with Delayed Graft Function after Kidney Transplantation

    A. Coca1, C. Arias-Cabrales2, M. Perez-Saez2, P. Gonzalez1, M. Crespo2, M. Rollan1, B. Toribio1, A. Mendiluce1, J. Pascual2, J. Bustamante-Munguira3

  • Increased Level of Serum Cholesterol and Apoptosis Together Induces the Development of Liver Fibrosis and Early Allograft Loss

    B. H. Ozdemir1, G. Ozgun1, E. H. Ayvazoglu Soy2, N. Haberal1, M. Haberal2

  • Increased Mitochondrial Metabolic Enzymes are Associated with Superior Kidney Function after Normothermic Ex-Vivo Kidney Perfusion-A Proteomics Study

    C. McEvoy1, S. Clotet-Freixas1, T. Tokar2, C. Pastrello2, S. Reid3, I. Batruch4, A. RaoPeters5, P. Urbanellis1, M. Kaths1, S. Farkona1, J. Van3, B. Urquhart5, I. Jurisica2, L. Robinson6, M. Selzner1, A. Konvalinka1

  • Increased Post-Operative Ventilation Time in Lung Transplant Recipients with Left Ventricular Diastolic Dysfunction

    E. Klipsch1, R. Rachwan2, I. KutKut3, D. Roe2, C. Hage2, T. Hathaway1, R. S. Mangus2

  • Increased Transplant Surgery Advanced Practice Provider Involvement Associated with Decreased Hospital Length of Stay and Readmissions Following Kidney Transplantation

    E. A. Herriman1, J. R. Montgomery2, K. J. Brown1, K. J. Woodside1

  • Increasing Access to Kidney Transplantation Through a Satellite Clinic

    R. H. Naik, E. Ramos, B. Paueksakon, A. Lyles, L. Smith, J. Lawson, E. Zavala, S. Shawar, J. H. Helderman, S. Karp, D. Shaffer, R. Forbes, B. P. Concepcion

  • Increasing Prevalence and Diversity: Alcoholic Liver Disease in Liver Transplant Candidates

    M. Joshi, E. L. Godfrey, J. A. Goss, A. Rana

  • Increasing Utilization of Anonymous Nondirected Living Liver Donors in the United States

    M. H. Raza1, M. Lo2, Y. Genyk3, L. Sher3, J. Emamaullee3

  • Increasing Utilization via Accelerating the Placement of Hard-to-Place Kidneys

    S. Noreen1, R. Brown1, Y. Becker2, M. Cooper3, K. O'Connor4, J. Prinz5, D. Klassen1

  • Individualized Impact of Donation after Cardiac Death on Kidney Transplant Outcomes

    S. Bae, A. Massie, J. Garonzik Wang, D. Segev

  • Inducing Donor MHC Chimerism with Bone Marrow Derived Exosomes in Non-Human Primates

    P. M. Patel1, B. A. Gonzalez Nolasco1, J. A. Morrissette1, A. Prunevieille1, K. J. Ahrens1, J. M. O1, D. C. Becerra1, G. Benichou1, J. C. Madsen2

  • Induction Immunosuppression in Primary Pediatric Liver Transplant Recipients

    T. Shaker1, K. Ramanathan1, S. Riad2, D. Vock3, S. Chinnakotla1

  • Induction Immunosuppression with Thymoglobulin May Improve Graft Outcomes without Increasing a Risk for Infection in Patients Undergoing Liver Transplantation Alone

    M. Henry1, T. Kitajima2, J. Konel1, S. Yeddula2, M. Rizzari2, K. Collins2, D. Moonka2, A. Yoshida2, M. Abouljoud2, S. Nagai3

  • Induction of Delayed Immune Tolerance after Reconstructive Transplantation by Combining Donor Bone Marrow Transplantation and High-Dose Cyclophosphamide Treatment

    Y. Guo1, F. Messner1, B. Oh1, G. Furtmüller1, W. Lee1, D. Cooney1, L. Luznik2, G. Brandacher1

  • Induction of Transplant Tolerance by Modulating the Metabolic Stress Pathways

    X. Xiao, L. Zhang, Y. Ying, Y. Wang, P. Arnold, Z. Zhang, X. Li

  • Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients in the Current Era of Immunosuppression

    M. Zachariah1, I. Mallawaarachchi2, N. Meeks3, D. Wright1, R. Minawala1, V. Liu1, J. Rolls4, S. Hussein4, C. Jarrin5

  • Inequitable Access to Living Donor Kidney Transplantation in Black and Asian Minority Ethnic Groups in the UK: A Single Centre Cross-Sectional Cohort Study

    A. Cronin, K. Sran, R. Gokmen, A. Copley, L. Silas, R. Zakri

  • Infections in Simultaneous Pancreas/Kidney Transplant (SPKT) Recipients

    J. W. O'Neill1, M. J. Copeland2, S. D. Schrank2, M. Cooper3, P. Abrams3, B. Javaid3, J. G. Timpone2

  • Infectious Complications and Malignancy after Kidney Transplantation in the Elderly Population

    L. Liriano-Ward, M. Parides, Y. Al Azzi, C. Pynadath, M. Ajaimy, J. Graham, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin

  • Infectious Complications in Elderly Kidney Transplant Recipients Undergoing Desensitization

    S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang

  • Infectious Tolerance Depends Upon the ‘Exokine’ IL35

    W. J. Burlingham1, J. A. Sullivan1, Y. Tomita2, E. Jankowska-Gan1, D. Lema1, S. Hong3, D. A. Vignali4

  • Inflammatory Cytokines Have a Different Effect from One HLA-II Subclass to Another on Human Endothelium

    S. Beland, F. Bouchard-Boivin, A. Gama, O. Desy, S. A. De Serres

  • Influence of HLA Compatibility on Cytomegalovirus Infection Post-Kidney Transplantation

    N. Fujiyama1, M. Saito2, R. Yamamoto2, K. Numakura2, T. Inoue2, R. Sagehashi2, K. Hosomichi3, A. Miura1, T. Habuchi2, S. Satoh1

  • Influence of Human Leukocyte Antigen Status and Gender of Positive Crossmatch Patients on Long-Term Survival Outcomes of Antibody Incompatible Renal Transplantation

    N. R. Macha1, A. Abimbola1, N. Khovanova2, D. Briggs3, N. Krishnan4

  • Influence of Microbial Communities on Transplantation

    K. Janek1, J. Fechner1, K. Krautkramer2, S. Sudakaran3, J. Denu4, J. Handelsman3, F. Rey5, E. Vivas5, J. Mezrich1

  • Influence of Nonclinical Factors on Adult Liver Organ Donor Offer Decision Making in the United States

    S. Meade, M. Simpson, B. J. Kane, C. J. Simon, Y. Cheah, R. L. Jenkins, M. E. Akoad

  • Influence of the Gut Microbiota on Acute Rejection of Vascular Allografts

    J. C. Choy, K. Rey, W. Enns, T. Van Rossum, F. S. Brinkman

  • Influenza-Associated Hospitalizations in Pediatric Solid Organ Transplant Recipients

    Z. Haddadin1, V. Probst1, H. Rahman1, M. Hall2, C. Thurm2, N. Halasa1, J. Godown3, D. E. Dulek1

  • Informed Consent and Decision Making for Upper Extremity VCA

    B. Kuramitsu1, C. Berumen1, A. Ferzola2, H. Sung2, C. Kim3, D. Scarton3, T. McHugh3, A. Schultheis3, T. Riggleman3, J. Taylor3, M. Henderson2, G. Brandacher2, S. Tintle3, E. Gordon1

  • Inhibiting NLRP3 Inflammasome Ameliorates Glucose Fluctuation Through Reducing Apoptosis and Infiltration of Inflammatory Cells after Intraportal Islet Transplantation in Rodent Model

    G. Yoshimatsu, T. Matsuoka, K. Chinen, N. Sakata, S. Kodama

  • Initial Case Series of Pure Laparoscopic Donor Hepatectomy in Cleveland Clinic

    K. Sasaki, F. Aucejo, M. Fujiki, T. Diago Uso, B. Eghtesad, C. MIller, C. Quintini, K. Hashimoto, C. D. Kwon

  • Initial Experience of the First 13 Cases of Purely Laparoscopic Living Donor Right Hepatectomy

    H. Choi1, C. Seo1, J. Ahn1, G. Na2, Y. You1

  • Initial North American Experience in Renal Transplantation from Medical Assistance in Dying Donors

    M. A. Levine, S. Sami, A. Sener, P. Luke

  • Integrated Multicohort Analysis of Transcriptome Profiles Identifies Blood Gene Signature to Distinguish Rejection from Infection in Patients with Solid Organ Transplants

    L. C. Murphy, A. Rao, M. Donato, P. Khatri

  • Interferon-Beta Acts Directly on T Cells to Promote Foxp3 Acetylation in Regulatory T Cells

    F. Fueyo-González, L. Anderson, P. Cravedi, P. S. Heeger, M. Fribourg

  • Interim Experience in a Phase 3 Prospective, Randomized, Multi-Center, Open-Label, Controlled Trial of Cellular Immunotherapy with MDR-101 for Induction of Immune Tolerance in Recipients of HLA-Matched, Living Donor Kidney Transplants

    D. Kaufman1, J. Piper2, M. Stegall3, S. Akkina4, E. Marin5, A. Gaber6, Y. Qasi7, T. Srinivas8, D. Alonso9, A. Patel10, M. Laftavi11, A. Shah12, S. Collette13, E. Stites14, K. Chavin8, S. Crowley15

  • Interstitial Inflammation with Chronic Allograft Injury Best Predicts Graft Loss

    M. Ajaimy, M. Parides, A. Colovai, Y. Azzi, L. Liriano Ward, P. Nandigam, J. Rocca, M. Kinkhabwala, S. Greenstein, J. Graham, E. Akalin

  • Intestinal Retransplantation: Survival Outcomes Similar to Primary Transplantation

    C. Beyersdorf, L. Vargas, D. Mercer, W. Grant, A. Langnas, S. Merani

  • Intimal Arteritis in Association with Microvascular Inflammation Leads to Inferior Graft Survival Regardless DSA

    M. Novotny1, E. Honsova2, O. Viklicky1

  • Intra-Lymph Node Injection of Microparticles Reprograms the Laminin Stromal Network to Prolong Allograft Survival

    C. M. Paluskievicz1, Y. Xiong1, W. Piao1, M. Willson-Shirkey1, H. Eppler2, C. M. Jewell2, J. S. Bromberg1

  • Intra-Lymph Node Injection of Rapamycin-Alloantigen Microparticles Regulates Dendritic Cell Antigen Presentation

    C. M. Paluskievicz1, Y. Xiong1, W. Piao1, M. Willson-Shirkey1, H. Eppler2, C. M. Jewell2, J. S. Bromberg1

  • Intraoperative Oxygen Delivery and Acute Kidney Injury after Liver Transplantation

    W. Kim, H. Lee, H. Yoon, K. Suh

  • Intravenous Administration of Mitochondria Minimizes Liver Ischemia Reperfusion Injury in Lean and Diet Induced Obese Mice

    T. Rousselle1, E. Patterson1, C. Kuscu1, J. Pierre2, C. Kuscu1, J. Eason1, D. Maluf1, V. Mas1, A. Bajwa1

  • Introducing the Smartphone App, EL-FIT (Exercise & Liver FITness), to Help Monitor and Prehabilitate Liver Transplant Candidates

    A. Duarte-Rojo1, P. M. Bloomer1, R. J. Rogers2, M. A. Dunn1, E. B. Tapper3, R. Bataller1, C. B. Hughes1, A. A. Ferrando1, W. R. Kim4, J. M. Jakicic2

  • Introduction of Preemptive Pharmacogenomic Testing in Kidney Transplant Recipients: Early Evaluation of the Clinical Impact of Genomic Guided Tacrolimus Dosing

    G. Girone1, V. Do1, K. Belfield1, R. Pulk1, E. Cohen1, E. Marin2

  • Invasive Aspergillosis in Lung Transplant Recipients with Aspergillus Colonization Beyond One Year after Transplant

    S. Davoudi, A. Pérez-Cortés Villalobos, T. Martinu, J. Tikkanen, D. Kumar, A. Humar, L. G. Singer, S. Keshavjee, S. Husain

  • Invasive Mould Infection in Transplant Recipients with Influenza: A 5-Year Retrospective Review

    P. Phoompoung, S. Husain, L. Singer, A. Humar, D. Kumar

  • Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Amyloidosis

    P. Banankhah1, G. Liu1, J. Nattiv1, C. Lum2, A. Salimbangon3, A. Wolfson4, E. DePasquale1, R. Chand5, P. Genyk1, P. Kingsford1, J. Li1, D. Vucicevic6, A. Vaidya1, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, A. Kiankhooy1, S. Hashmi1, S. Nuno1, J. Pizula1, D. Miklin1, A. E. Lee1, K. Yang1, S. Shah1

  • Investigating the 6-Month Effects of the UNOS Allocation System Changes on the Post Transplant Outcomes in Patients with Hypertrophic Cardiomyopathy

    P. Banankhah1, C. Lum2, A. Salimbangon3, G. Liu1, A. Wolfson4, E. DePasquale1, R. Chand5, P. Genyk1, P. Kingsford1, J. Li1, D. Vucicevic6, A. Vaidya1, K. Pandya1, J. Rahman1, M. Fong1, L. Grazette1, J. Nattiv1, S. Hashmi1, S. Nuno1, J. Pizula1, A. Lee1, K. Yang1, S. Shah1

  • Investigation of Il35 Expressing Regulatory B Cells in Tolerance of Kidney Transplantation

    J. A. Sullivan, J. H. Fechner, E. Jankowska-Gan, W. J. Burlingham, D. B. Kaufman

  • Ion AmpliSeq RNA Expression Panel Evaluated by Next-Generation Sequencing (NGS) Can Detect Genes in Human Formalin-Fixed Paraffin-Embedded Kidney Biopsies to Predict T Cell and Antibody Mediated Rejection in Renal Allografts

    P. Ruiz1, E. Margolles-Clark1, G. Guerra2, A. Mattiazzi2, M. Ortigosa-Goggins2, G. Ciancio1, L. Chen1, G. Burke1

  • Irf8-Relevant Mechanism in B Cell Regulation In Vitro

    Q. Fu1, K. Deng2, H. Yang1, J. F. Markmann2, S. Deng1

  • Is 3-4+ Liver Fibrosis a Contraindication to Heart Transplantation?

    M. Kittleson, J. Patel, D. Chang, E. Kransdorf, D. Geft, K. Nishihara, A. Shen, B. May, L. Czer, F. Esmailian, J. A. Kobashigawa

  • Is Azathioprine the Right Choice in De Novo Lung Transplantation?

    A. Chan1, B. Sirandas1, A. Carlson1, C. Truax1, B. Clark1, I. Hall2, B. Cahill3, L. Smith1

  • Is Bridging Anticoagulation or Antiplatelet Reversal Necessary Prior to Kidney Transplantation?

    J. C. Alonso-Escalante, R. P. Tindall, L. Machado, K. R. Tabar, N. Thai, T. Uemura

  • Is Dual Allocation Successful at Higher Remuzzi Scores? Outcomes of Dual Kidney Transplants at Remuzzi Scores of 8 or Greater

    V. Fleetwood1, C. Kensinger2, C. Papageorge1, D. Aufhauser1, G. Leverson3, B. Welch1, D. Foley1, P. Pasha1

  • Is Ischemia Reperfusion Injury Immediately after Heart Transplantation Correlated to Increased Intimal Thickening in the First Year?

    J. Patel, M. Kittleson, D. Chang, E. Kransdorf, D. Geft, A. Shen, K. Nishihara, A. Velleca, L. Czer, F. Esmailian, J. A. Kobashigawa

  • Is it Safe to Use Organs from Deceased Donor with Open Abdomen?

    G. El-Gazzaz, A. L. Friedman

  • Is it Time for Immune Screening for Belatacept-Treated Stable Kidney Transplant Patients for Adjust the Immunosuppression?

    M. C. Rial1, F. Caro2, N. Ambrosi2, D. Guerrieri2, A. Calleri1, E. Chuluyan1, D. Casadei1

  • Is the Epitope Mismatch Load Enough to Identify HLA-DQ Mismatches with a Low Risk for De Novo DSA Development?

    V. Jucaud1, M. Stegall2, C. Schinstock2, R. Heilman3, L. Rebellato4, M. Samaniego-Picota5, D. Leeser4, M. Gandhi2, J. Beaumont1, M. Everly1

  • Is the Survival Impacted by Multiple Cancer after Liver Transplantation? A Retrospective French National Multicentric Study between 1993-2013

    M. Altieri

  • Is Total Ischemic Time a Measure of OPTN Efficiency? Monitoring the Impact of Lung Allocation Policy on Ischemic Time

    A. M. Placona1, R. R. Goff1, P. Shay2, B. Carrico1

  • Isavuconazole (ISA) versus Voriconazole (VOR) Prophylaxis (px) in Lung Transplant Recipients (LTR)

    P. Samanta, C. J. Clancy, R. V. Marini, R. Rivosecchi, E. K. McCreary, R. K. Shields, B. A. Falcione, A. Viehman, L. Sacha, E. J. Kwak, F. P. Silveira, L. Clarke, M. H. Nguyen

  • Ischemic and Perfused Kidney Treated with Non-Cultured Adipose-Derived Regenerative Cells Increase the Immune and Regulatory Transcriptome

    R. Lathan1, R. Ghita1, R. Touyz1, M. Clancy2, P. Mark1

  • Isolation of Preformed Antibodies from Whole Blood by Integrating Acoustics and Microfluidics in Sensitized Animal Model

    J. Kwun1, Y. Gu2, M. Manook1, M. Wu1, J. Yoon1, S. Knechtle1, T. J. Huang2

Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences